p53 can suppress inflammatory response by inhibiting NF-kB activity [19] and since it is often mutated by cigarette smoke, oxidant activation of NF-kB may result in a chronic imbalance in COPD and lung cancer. This evidence concerns the gene NFKB1 and lung carcinoma.